| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Transmedics Group, Inc. (TMDX) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 46 sells. TMDX is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 495.0K | $39.00M | - | |
| Dir | 26.3K | $2.07M | -9,624 | |
| CFO | 16.0K | $1.26M | - | |
| Dir | 15.7K | $1.24M | - | |
| Other | 14.0K | $1.10M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 2024 | Basile Edward M64 | Director | Sale+OE | 6,750 | $149.96 | $1,012,229.66 | -36.2% | -45.6% | -23.9% | |
| Aug 1, 2024 | Khayal Tamer I53 | Chief Commercial Officer | Sale+OE | 2,958 | $156.77 | $463,727.17 | -1.0% | -45.9% | -20.4% | |
| Jul 15, 2024 | Hassanein Waleed H56 | President &CEO | Sale+OE | 8,625 | $145.17 | $1,252,050.99 | -2.6% | -7.0% | -19.9% | |
| Jul 1, 2024 | Khayal Tamer I53 | Chief Commercial Officer | Sale+OE | 2,958 | $151.40 | $447,852.94 | -2.6% | +4.5% | -13.4% | |
| Jun 14, 2024 | Hassanein Waleed H56 | President &CEO | Sale+OE | 8,625 | $141.85 | $1,223,473.20 | -2.6% | +5.0% | +0.6% | |
| Jun 5, 2024 | Basile Edward M64 | Director | Sell | 1,193 | $138.08 | $164,729.44 | -62.0% | +18.0% | +0.4% | |
| Jun 3, 2024 | Khayal Tamer I53 | Chief Commercial Officer | Sale+OE | 2,960 | $133.10 | $393,985.95 | -1.9% | +19.3% | -3.7% | |
| Jun 3, 2024 | Gordon Stephen52 | Chief Financial Officer | Sale+OE | 2,060 | $135.93 | $280,015.80 | -8.8% | +19.3% | -3.7% | |
| May 29, 2024 | Weill David63 | Director | Sell | 1,193 | $141.65 | $168,988.45 | -10.0% | +23.8% | -10.3% | |
| May 29, 2024 | Gordon Stephen52 | Chief Financial Officer | Sale+OE | 20,000 | $141.40 | $2,828,024.70 | -21.6% | +23.8% | -10.3% |